Release Date: 27/06/16 16:18 Summary: Completion of Compulsory Acquisition-BRS.AX Price Sensitive: No Download Document 90.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%